Trials / Terminated
TerminatedNCT03092765
Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
A Clinical Phase 2 Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- EA Pharma Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
This study is a placebo-controlled, randomized, double-blind, multicenter, parallel-group comparison study in primary biliary cholangitis participants inadequately responding to ursodeoxycholic acid.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | E6011 | Intravenous administration |
| DRUG | Placebo | Intravenous administration |
Timeline
- Start date
- 2017-05-29
- Primary completion
- 2018-08-27
- Completion
- 2018-10-22
- First posted
- 2017-03-28
- Last updated
- 2019-01-04
Locations
46 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03092765. Inclusion in this directory is not an endorsement.